Skip to main content
S 2032 116th Congress Senate Crime and Law Enforcement Congressional oversight Drug safety, medical device, and laboratory regulation Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Health personnel Health programs administration and funding Licensing and registrations Medical research Public-private cooperation Research administration and funding Trade restrictions

Cannabidiol and Marihuana Research Expansion Act

Introduced: June 27, 2019 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 10 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 16, 2020
Held at the desk.
Dec 16, 2020
Received in the House.
Dec 16, 2020
Message on Senate action sent to the House.
Dec 15, 2020
Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7504-7507)
Dec 15, 2020
Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.(text of amendment in the nature of a substitute: CR S7504-7507)
Dec 15, 2020
Measure laid before Senate by unanimous consent. (consideration: CR S7508)
Dec 15, 2020
Senate Committee on the Judiciary discharged by Unanimous Consent.
Oct 23, 2019
Committee on United States Senate Caucus on International Narcotics Control. Hearings held. Hearings printed: S.Hrg. 116-252.
Jun 27, 2019
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S4633-4634)
Jun 27, 2019
Introduced in Senate
 Amendments to this bill 1

1 agreed to

AmendmentSponsorPurposeStatusLatest action
SAMDT 2,708 — In the nature of a substitute. Agreed to Dec 15, 2020
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Cannabidiol and Marihuana Research Expansion Act

This bill modifies provisions concerning the federal regulation of certain drugs that are deemed to pose a risk of abuse and dependence to facilitate research on, and the use of, medical treatments containing marijuana and its derivatives.

What's happening now December 16, 2020

Held at the desk.

 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 9
All 9 Democratic 4 Republican 5
R
Murkowski, Lisa
Alaska · Oct 15, 2019
 R
Cramer, Kevin
North Dakota · Jun 27, 2019
 D
Durbin, Richard J.
Illinois · Jun 27, 2019
 R
Ernst, Joni
Iowa · Jun 27, 2019
 R
Grassley, Chuck
Iowa · Jun 27, 2019
 D
Kaine, Tim
Virginia · Jun 27, 2019
 D
Klobuchar, Amy
Minnesota · Jun 27, 2019
 D
Schatz, Brian
Hawaii · Jun 27, 2019
 R
Tillis, Thomas
North Carolina · Jun 27, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2032: Cannabidiol and Marihuana Research Expansion Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-2032/
MLA
"S. 2032: Cannabidiol and Marihuana Research Expansion Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-2032/.
Bluebook (legal)
S. 2032, 116th Cong. (2026), https://openamerica.io/bill/116-S-2032/.
Markdown link
[S. 2032: Cannabidiol and Marihuana Research Expansion Act](https://openamerica.io/bill/116-S-2032/)
Report a problem